The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

10 Jul 2020 17:03

RNS Number : 7254S
Templeton Emerging Markets IT PLC
10 July 2020
 

Stock Exchange Announcement

Templeton Emerging Markets Investment Trust PLC ("the Company")

Transaction in Own Shares

Legal Entity Identifier 5493002NMTB70RZBXO96

 

 

The Company announces that, on 10 July 2020, it purchased for cancellation 30,000 Ordinary shares of 25 pence each in the Company ("Shares") at a price of 817.33 pence per Share.

 

Following this transaction, the Company's share capital consists of 239,831,107 Shares in issue and 20,765,179 Shares held in Treasury. Therefore, the total number of voting rights in the Company is 239,831,107. In order to protect the interests of existing shareholders, shares held in treasury will only be reissued at a price above the prevailing NAV per share at the time of reissue.

 

This figure (239,831,107) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please e-mail CompanySecretarialEdinburgh@franklintempleton.com or contact Franklin Templeton Client Dealer Services via e-mail at enquiries@franklintempleton.co.uk  or via free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSFLFIRDLIILII

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.